Symbiosis acquires 20,000 sq/ft building in Stirling, UK, to house new high-tech medicines manufacturing capacity: Stirling, UK Thursday, October 10, 2024, 14:00 Hrs [IST] Symbios ...
Bayer, MOMA Therapeutics ink collaboration to develop and commercialize small molecule oncology programme: Berlin, Germany Thursday, October 10, 2024, 13:00 Hrs [IST] Bayer and MO ...
Sanofi to present data from Beyfortus to treat RSV diseases at IDWeek 2024 annual meeting: Paris Thursday, October 10, 2024, 12:00 Hrs [IST] Sanofi advances its ambition to protec ...
Leads Biolabs’ LBL-024 receives Breakthrough Therapy Designation from China NMPA to treat extrapulmonary neuroendocrine carcinoma: Nanjing, China Thursday, October 10, 2024, 10: ...
Pfizer to present data across respiratory and other infectious diseases portfolio at IDWeek 2024 congress: New York Thursday, October 10, 2024, 09:00 Hrs [IST] Pfizer Inc. will pr ...
NABH to conduct entry-level hospital assessors’ training programme in New Delhi from Oct 22 to 24: Shardul Nautiyal, Mumbai ...
Peethaambaran Kunnathoor, Chennai Thursday, October 10, 2024, 08:00 Hrs [IST] ...
NCCE recommends formation of expert committee to determine rates under Clinical Establishments Rules: Gireesh Babu, New Delhi Thursday, October 10, 2024, 08:00 Hrs [IST] The Natio ...
MvPI releases updated version of medical devices adverse event reporting form: Our Bureau, New Delhi Thursday, October 10, 2024, 08:00 Hrs [IST] The Materiovigilance Programme of ...
Adcendo gets US FDA clearance to begin ADCElerate-01 phase I/II trial of ADCE-D01 in patients with metastatic and/or unresectable STS: Copenhagen, Denmark Wednesday, October 9, 20 ...